Antibiotic prescribing in ambulatory pediatrics in the United States

Adam L Hersh1, Daniel J Shapiro, Andrew T Pavia

  • 1Department of Pediatrics, University of Utah, Salt Lake City, UT 84108, USA. adam.hersh@hsc.utah.edu

Pediatrics
|November 9, 2011
PubMed

Insights

Broad-spectrum antibiotic prescribing is common in pediatric care, often for conditions like viral respiratory infections where they offer no benefit. This inappropriate use contributes to antibiotic resistance and unnecessary costs.

Area of Science:

  • Pediatric infectious disease epidemiology
  • Antimicrobial stewardship
  • Public health policy

Background:

  • Antibiotics are frequently prescribed for pediatric conditions, including viral respiratory infections, where they lack therapeutic benefit.
  • Increasing use of broad-spectrum antibiotics incurs costs and drives antimicrobial resistance.

Purpose of the Study:

  • To conduct a national analysis of antibiotic prescribing patterns in pediatric ambulatory care.
  • To examine antibiotic classes and diagnostic categories, focusing on broad-spectrum antibiotic prescribing factors.

Main Methods:

  • Utilized data from the National Ambulatory and National Hospital Ambulatory Medical Care surveys (2006-2008).
  • Estimated antibiotic and broad-spectrum antibiotic prescribing rates by diagnostic category for patients under 18.
  • Employed multivariable logistic regression to identify factors associated with broad-spectrum antibiotic use.

Main Results:

  • Antibiotics were prescribed in 21% of pediatric ambulatory visits, with 50% being broad-spectrum (commonly macrolides).
  • Respiratory conditions represented over 70% of visits involving antibiotic and broad-spectrum antibiotic prescriptions.
  • Over 10 million annual visits for respiratory conditions received antibiotics inappropriately; factors linked to broad-spectrum use included these conditions, younger age, Southern region visits, and private insurance.

Conclusions:

  • Broad-spectrum antibiotic prescribing is prevalent and often inappropriate in pediatric ambulatory settings.
  • Findings highlight key areas for targeted antibiotic stewardship interventions in ambulatory care, including specific regions, diagnoses, and patient demographics.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...